University of Pittsburgh: Lung Diseases trials
The registry lists 13 Lung Diseases studies with University of Pittsburgh as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 1 1Phase 3 1Phase 4 2No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPDCompletedNCT01745848Phase 4Results posted
- Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant RecipientsCompletedNCT00841971Phase 4Results posted
- Dysbiosis Impact on Lung Disease in HIVCompletedNCT04155684
- Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)CompletedNCT03572335
- Longitudinal Evaluation of HIV-associated Lung Disease PhenotypesCompletedNCT02238327
- Vascular Subphenotypes of Lung Disease in HIV & COPDCompletedNCT01581086
- Lung HIV Disease in a Large Cohort-PittCompletedNCT01326572
- Comparing Methods for Tracking Health Information at Home After Lung TransplantCompletedNCT00818025Not applicable
- Aerosol Cyclosporine in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00783107Phase 1
- Abelcet Radiotagging Protocol: Inhaled Lipid Complex Abelcet® in Lung Transplant RecipientsTerminatedNCT00235651Phase 3
- Study of the Economics of Pulmonary Artery Catheter Use in Patients With Acute Respiratory Distress Syndrome (ARDS)CompletedNCT00234767
- Prolonged Outcomes After Nitric Oxide (PrONOx)CompletedNCT00234247
- Genetic Factors That Influence Chronic Obstructive Pulmonary Disease in HispanicsCompletedNCT00106470